MedTrace Logo

Characterization of Human Intestinal Macrophages in Metabolic Disease

NCT03796000 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2022-06-23

No results posted yet for this study

Summary

This is a prospective, observational study aiming at improving the understanding of the pathophysiology of metabolic disease. As inflammation has been recognized as a key characteristic of metabolic disease but its starting point is still unknown, the investigators' aim is to characterize intestinal macrophages from human gut biopsies taken in diagnostic endoscopies of the gastrointestinal tract or in bariatric surgeries for clinical reasons.

Conditions

  • Metabolic Disease

Interventions

PROCEDURE

tissue samples, blood and stool sample

Tissue samples from gastroscopy/colonoscopy.

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Claudia Cavelti-Weder, PD Dr. med. · University Hospital, Basel, Switzerland

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-14
Primary Completion
2022-04-14
Completion
2022-05-14

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03796000 on ClinicalTrials.gov